Session 3 Summary cards Flashcards

(18 cards)

1
Q

Disorders that show anticipation.

A
  1. HD
  2. FraX
  3. DM1
  4. Dentatorubro-pallidoluysian atrophy
  5. SCA1
  6. SCA3
  7. SCA7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Examples of age related mosaicism. Cause.

A

Failure in DNA repair mechanism evidenced by NF2
Classic and mosaic forms are germline and have a higher frequency of frameshift mutations that somatic form - sporadic vestibular schwannoma.

Other examples: cancer, loss/gain of sex chromosomes with age.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Example of mutation with reduced penetrance

A

c.907_909 del, Glu303del in TOR1A causing early onset primary dystonia.

30% penetrance. OK if not symptoms by 28

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Example of condition with reduced penetrance

A

Breast cancer due to BRCA1 mutation. 80% lifetime risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Examples of sex-limiting genes.

A

LHCGR (2p16.3) precocious male puberty. Constiutive activation of LH receptor (hypermorph)

Blepharophimosis, ptosis and epicathis inverusus (BPES) Type 1 (3q22.3) FOLXL2 polyalanine expansion. Predominantly expressed in ovaries resulting in POI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Example of epistasis

A

Bombay phenotype.

Can lead to locus heterogenity. Same phenotype resulting from multiple genes, usually in same pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Example of pleiotropy.

A

PKU

Phe –> Tyr –> Melanin

Increased Phe = PKU
Reduced Tyr = reduced melanin = albinism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Gene associated with XLD hypophosphatemia

A

PHEX (Xq22.1)

stimulates FGFR23 expression in bone and normal bone dev.

FGF23 inhibits phosphate reabsorption in kidney required for normal bone formation.

PHEX mutation leads to increase in FGF23 overactivity or means FGF23 is not broken down properly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Examples of XLD conditions, gene, locus

A
  1. XLD hypophosphataemia (PHEX, Xq22.1)
  2. Alport Syndrome (COL4A5, Xq22.3)
  3. Fragile X (FMR1, Xq27.3)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of XLD conditions with male lethality gene, locus

A
  1. Intercontinentia pigmentia (IKBKG, Xq28)
  2. Rett syndrome (MECP2, Xq28, CDKL5, Xp22.5) FOXG1 causes congenital/earlier onset form at 14q12
  3. Oral-facial-digital syndrome 1 (OFD1 Xp22,2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Example of XLD where males unaffected

A

Craniofrontonasal syndrome caused by mutations in ephrin gene (EFNB1, Xq13.1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What makes the terms X-linked dominant/recessive difficult to use in practise? 5

A
  1. Does not capture variable expressivity of x-linked disorders
    2) Does not take into account the multiple mechanisms that can result in disease expression in females
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

XLR disorders, gene, locus

A
  1. DMD/BMD/DMD-assiocated cardiomyopathy (dystrophin Xp21.1-2)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of females affected with XLR

A
  1. XO
  2. Del of other allele
  3. Translocation/rearrangement disrupting XIC
  4. UPD
  5. Somatic mosaic
  6. Skewing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Mutation spectrum of DMD/BMD

A

Del/dup of 1 or more exons account for
65-70% of DMD
80-85% of BMD

Two hotspots:

1) 80% of dels in 44-53
2) 20% of dels in exons 2-20 (5’)

Duplication freqs are opposite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

XLR disorders and proposed gene therapy treatments.

A
  1. DMD -
    stop codon readthrough applicable to 15% patients
    exon skipping therapy applicable to ~80% of DMD
  2. Haemophilia A/B: IV adeno-associated viral vectors expressing Factor 8 or 9
17
Q

AR disorder and proposed gene therapy treatments.

A

SMA:
1) 18mer ASO010-27 (ISIS-SMN) in phase III trials for SMA infant - splicing modifier
2) scAAV9 carrying WT SMN gene. AveXis in phase I trials.
Potential microRNA biomarkers for treatment monitoring via blood test

18
Q

Examples of single gene haploinsufficient disorders, gene, locus

A
  1. Familial hyerptrophic cardiomyopathy/HCM
    - MYH7 (14q11.2)
    - TNNT2 (1q32.1)
    - TNNT3 (11p15.5)
  2. Dilated cardiomypathy - LMNA
  3. Alagille syndrome
    - JAG1 (20p12.2)
    - NOTCH2 (1p12)
  4. Aniridia (11p13)
  5. GLUT1 deficiency syndrome (1p34.2)
  6. HNPP (PMP22, 17p12)